July 26, 2019
The Senate Finance Committee on Thursday voted 19-9 to advance a bipartisan bill aimed at lowering prescription drug costs, but the bill might face opposition in the full Senate unless it undergoes substantial revisions.
July 25, 2019
HHS Secretary Alex Azar on Tuesday laid out three of the Trump administration's top health care priorities heading into the 2020 election.
July 24, 2019
Senate Finance Committee Chair Chuck Grassley (R-Iowa) and Sen. Ron Wyden (D-Ore.), the ranking member on the committee, on Tuesday introduced a sweeping bill aimed at lowering prescription drug costs by changing various Medicare and Medicaid policies, but the bill quickly drew criticism from congressional Republicans and the pharmaceutical industry.
Major issues at Indian Health Service hospitals have led to unsafe conditions for patients, risky opioid prescribing practices, and information technology vulnerabilities, according to two reports released Monday by HHS' Office of Inspector General.
23andMe is piloting an effort to collect more health data from its customers, including lab results, prescription information, and medical history.
HHS and the Department of Defense under a new partnership with pharmaceutical company VenatoRx will invest up to $100 million to help develop an antibiotic that can treat antibiotic-resistant superbugs, the departments announced Monday.
July 17, 2019
Fortune last week released its "40 under 40" list of the most influential "entrepreneurs, leaders, and iconoclasts" under 40 years old, including 19 who are known for their contributions to the health care and wellness industries.
CMS on Monday announced a proposal to cover acupuncture for Medicare beneficiaries with chronic low-back pain who are enrolled in NIH-sponsored or CMS-approved clinical trials that are evaluating acupuncture as an alternative treatment to opioids.
July 16, 2019
Sens. Kirsten Gillibrand (D-N.Y.), Kamala Harris (D-Calif.), and Amy Klobuchar (D-Minn.), who each are seeking the 2020 Democratic nomination for president, have announced separate plans to address high prescription drug costs in the United States.
Evidence shows that urinary tract infections are becoming increasingly resistant to the routine course of antibiotics, leading to more serious illnesses, increased hospitalizations, and extended discomfort for patients.
Advisory Board. All rights reserved.